olivLaw · US equity research
Hydrofarm Holdings Group, Inc. HYFM
Wholesale-Miscellaneous Nondurable Goods · SIC 5190 · Vertical: Wholesale — nondurable goods (SIC 51xx)
Hydrofarm is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, with sales concentrated in the United States and Canada. The company is in a difficult period, marked by an outstanding term loan and ongoing talks with lenders, so the current question is whether it can stabilise its liquidity. Net sales for fiscal 2025 were $134.3 million, and in the second quarter of 2026 they fell to $23.2 million.
At the close of 04 Nov 2026, Hydrofarm Holdings Group, Inc. (HYFM) stock was 0.76 USD (+12.69% on the day), with market capitalisation 3.6 m USD, beta 1.54, 52-week range 0.54–2.44 USD. Latest reported quarter (Q2 2026): revenue of 23.2 m USD (−40.9% YoY), net income of -10.6 m USD, diluted EPS -2.23 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 44.9
- weak (30–45)
- Bollinger (20, 2)
- 0.64 – 0.90
- in the lower half of the band · %B 0.43 · band width 33.4%
- SMA 50 / 200
- 0.88 / 1.06
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.05 / -0.05
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −22.2% | −1.1% | −21.1 pp | — |
| 3 months | −53.4% | −0.5% | −52.9 pp | — |
| 6 months | −33.8% | +4.4% | −38.2 pp | — |
| Year to date | −50.0% | +12.3% | −62.3 pp | — |
| 1 year | −68.5% | +13.5% | −82.1 pp | −0.6% |
| 3 years | −92.9% | +76.4% | −169.4 pp | +8.8% |
| 5 years | −99.8% | +63.7% | −163.5 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 44.0 m | 37.3 m | 40.5 m | 39.2 m | 29.4 m | 25.1 m | 28.5 m | 23.2 m |
| Cost of revenue | 35.5 m | 35.5 m | 33.7 m | 36.5 m | 25.9 m | 23.0 m | 26.7 m | 20.6 m |
| Gross profit | 8.5 m | 1.8 m | 6.9 m | 2.8 m | 3.4 m | 2.1 m | 1.8 m | 2.6 m |
| SG&A | 17.6 m | 17.0 m | 17.9 m | 16.1 m | 16.4 m | 9.6 m | 10.6 m | 10.1 m |
| Operating income | -9.0 m | -15.1 m | -11.0 m | -13.3 m | -13.0 m | -239.6 m | -8.7 m | -7.4 m |
| Depreciation & amortisation | 7.7 m ≈ | 7.4 m | 7.3 m | 1.5 m | 7.3 m ≈ | 1.1 m | 1.0 m | 988.0 k |
| Interest expense | 3.9 m | 3.6 m | 3.4 m | 3.4 m | 3.3 m | 3.3 m | 5.9 m | 3.5 m |
| Pre-tax income | -12.9 m | -17.5 m | -14.3 m | -17.0 m | -16.3 m | -243.0 m | -14.7 m | -10.9 m |
| Income tax | 279.0 k | 4.0 k | 82.0 k | -98.0 k | 125.0 k | -849.0 k | -108.0 k | -225.0 k |
| Net income | -13.1 m | -17.5 m | -14.4 m | -16.9 m | -16.4 m | -242.2 m | -14.6 m | -10.6 m |
| Diluted EPS | -2.86 | -3.80 ≈ | -3.12 | -3.63 | -3.51 | -51.89 ≈ | -3.07 | -2.23 |
| Operating cash flow | -4.5 m ≈ | 2.7 m | -11.8 m | 1.7 m ≈ | -37.0 k ≈ | -4.0 m | -759.0 k | 52.0 k ≈ |
| Capex | 812.0 k ≈ | 270.0 k | 244.0 k | 281.0 k ≈ | 170.0 k ≈ | 329.0 k | 19.0 k | 61.0 k ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 235.1 m | 342.2 m | 479.4 m | 344.5 m | 226.6 m | 190.3 m | 134.3 m |
| Revenue YoY | unavailable | +45.6% | +40.1% | −28.1% | −34.2% | −16.0% | −29.4% |
| Net income | -40.1 m | -7.3 m | 13.4 m | -285.4 m | -64.8 m | -66.7 m | -289.8 m |
| Net income YoY | unavailable | unavailable | unavailable | −2,227.4% | unavailable | unavailable | unavailable |
| Diluted EPS | -1.94 | -0.46 | 0.31 | -6.35 | -14.24 | -14.51 | -62.35 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | −2,148.4% | unavailable | unavailable | unavailable |
| net % | -17.0% | -2.1% | 2.8% | -82.8% | -28.6% | -35.1% | -215.9% |
| Free cash flow | -14.1 m | -46.3 m | -50.5 m | 13.8 m | 2.8 m | -3.2 m | -15.1 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 6.3 m USD
- Financial debt
- 111.9 m USD
- Net debt
- 105.6 m USD
- Equity
- -63.3 m USD
- Total assets
- 123.8 m USD
- Debt / equity
- unavailable
- Current ratio
- 0.37x
- ROE
- unavailable
- ROA
- -105.4%
- FCF margin
- -11.2%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 342.2 m | 479.4 m | 344.5 m | 226.6 m | 190.3 m | 134.3 m | SEC (XBRL)· 27 Mar 2026verified |
| Cost of revenue | 278.6 m | 377.9 m | 315.2 m | 189.0 m | 158.2 m | 119.0 m | SEC (XBRL)· 27 Mar 2026verified |
| Gross profit | 63.6 m | 101.5 m | 29.3 m | 37.6 m | 32.1 m | 15.2 m | SEC (XBRL)· 27 Mar 2026verified |
| SG&A | 58.5 m | 104.2 m | 118.6 m | 87.3 m | 72.8 m | 59.9 m | SEC (XBRL)· 27 Mar 2026verified |
| Operating income | 4.3 m | -2.7 m | -281.6 m | -49.7 m | -52.2 m | -276.9 m | SEC (XBRL)· 27 Mar 2026verified |
| Depreciation & amortisation | 6.8 m | 14.9 m | 41.5 m | 32.1 m | 30.7 m | 23.1 m | SEC (XBRL)· 27 Mar 2026verified |
| EBITDA | 11.1 m ≈ | 12.2 m ≈ | -240.1 m ≈ | -17.6 m ≈ | -21.5 m ≈ | -253.8 m ≈ | SEC (XBRL)· 27 Mar 2026derived |
| Interest expense | 10.1 m | 2.1 m | 11.0 m | 15.4 m | 15.2 m | 13.4 m | SEC (XBRL)· 27 Mar 2026verified |
| Pre-tax income | -6.7 m | -5.7 m | -291.9 m | -65.0 m | -65.8 m | -290.5 m | SEC (XBRL)· 27 Mar 2026verified |
| Income tax | 576.0 k | -19.1 m | -6.4 m | -213.0 k | 869.0 k | -740.0 k | SEC (XBRL)· 27 Mar 2026verified |
| Net income | -7.3 m | 13.4 m | -285.4 m | -64.8 m | -66.7 m | -289.8 m | SEC (XBRL)· 27 Mar 2026verified |
| Diluted EPS | -0.46 | 0.31 | -6.35 | -14.24 | -14.51 | -62.35 | SEC (XBRL)· 27 Mar 2026verified |
| Weighted average diluted shares | 21.3 m | 43.0 m | 45.0 m | 4.6 m | 4.6 m | 4.6 m | SEC (XBRL)· 27 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 75.2 m | 26.6 m | 21.3 m | 30.3 m | 26.1 m | 6.3 m | SEC (XBRL)· 27 Mar 2026verified |
| Receivables | 21.6 m | 41.5 m | 17.2 m | 16.9 m | 14.8 m | 8.2 m | SEC (XBRL)· 27 Mar 2026verified |
| Inventories | 88.6 m | 189.1 m | 111.4 m | 75.4 m | 50.6 m | 33.3 m | SEC (XBRL)· 27 Mar 2026verified |
| Current assets | 199.9 m | 269.4 m | 154.9 m | 128.1 m | 95.2 m | 51.4 m | SEC (XBRL)· 27 Mar 2026verified |
| Property, plant & equipment, net | 4.0 m | 50.5 m | 51.1 m | 47.4 m | 37.5 m | 30.3 m | SEC (XBRL)· 15 May 2026verified |
| Goodwill | 0 | 204.9 m | 0 | — | — | — | SEC (XBRL)· 09 Mar 2023verified |
| Intangibles (excl. goodwill) | 52.4 m | 314.8 m | 300.4 m | 275.9 m | 249.0 m | 2.8 m | SEC (XBRL)· 27 Mar 2026verified |
| Total assets | 275.8 m | 891.2 m | 573.6 m | 507.6 m | 426.1 m | 123.8 m | SEC (XBRL)· 27 Mar 2026verified |
| Accounts payable | 22.6 m | 26.7 m | 13.6 m | 12.6 m | 12.3 m | 9.8 m | SEC (XBRL)· 27 Mar 2026verified |
| Short-term debt | 746.0 k | 2.3 m | 1.3 m | 3.0 m | 1.3 m | 111.9 m | SEC (XBRL)· 27 Mar 2026verified |
| Long-term debt | 290.0 k | 123.9 m | 117.5 m | 115.4 m | 114.7 m | 50.0 k | SEC (XBRL)· 27 Mar 2026verified |
| Current liabilities | 48.7 m | 88.4 m | 41.6 m | 37.7 m | 35.0 m | 140.0 m | SEC (XBRL)· 27 Mar 2026verified |
| Total liabilities | 64.9 m | 256.1 m | 223.7 m | 217.0 m | 202.4 m | 187.1 m | SEC (XBRL)· 27 Mar 2026verified |
| Equity | 210.9 m † | 635.2 m † | 349.9 m † | 290.6 m † | 223.7 m † | -63.3 m † | SEC (XBRL)· 27 Mar 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -44.8 m | -45.1 m | 22.0 m | 7.0 m | -324.0 k | -14.1 m | SEC (XBRL)· 27 Mar 2026verified |
| Capex | 1.4 m | 5.4 m | 8.2 m | 4.2 m | 2.9 m | 1.0 m | SEC (XBRL)· 27 Mar 2026verified |
| Free cash flow | -46.3 m ≈ | -50.5 m ≈ | 13.8 m ≈ | 2.8 m ≈ | -3.2 m ≈ | -15.1 m ≈ | SEC (XBRL)· 27 Mar 2026derived |
| Investing cash flow | 546.0 k | -468.2 m | -8.5 m | -4.2 m | 1.7 m | -841.0 k | SEC (XBRL)· 27 Mar 2026verified |
| Financing cash flow | 88.1 m | 464.7 m | -20.2 m | 6.1 m | -4.8 m | -5.4 m | SEC (XBRL)· 27 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 5 of at least 6
- score weight coverage: 33.3% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 3.6 m USD
Key indicators
Coverage and freshness
Score by group
33% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 12.71 – 97.71 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)12.71 – 97.71 (Mid 31.37)WACC 5.2% · starting FCFF 8.1 m USD · terminal value share of EV 88%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: no growth between −30% and +40% justifies the price
- Peers: EV/EBITDAunavailable · the base of the ratio is not positive
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 5 of at least 6; score weight coverage: 33.3% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -267.2% | 5 (vs peers) | 19% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -27.0% | 0 (on a fixed band) | 25% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -16.8x | 0 (on a fixed band) | 19% |
| Current ratio · Balance sheet | 0.3x | 0 (on a fixed band) | 13% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -145.6% | 0 (on a fixed band) | 25% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet0/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality· partial5/100 · 1/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partial0/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
HYDROFARM HOLDINGS GROUP, INC. (HYFM). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 134.3 m USD in 2025; YoY growth -29.4%; net margin -267.2%; ROE -535.5%.
The estimated value range is 12.71–97.71 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 31.37 USD, the price of 0.76 USD leaves a potential of 4,055.6% (value / price − 1) and a margin of safety of 97.6% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (indicators available: 5 of at least 6; score weight coverage: 33.3% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- The price is below the estimated value range
What contradicts it
- Net margin: -267.2%
- Revenue CAGR 3Y: -27.0%
- Interest coverage: -16.8x
- Current ratio: 0.3x
- FCF yield: -145.6%
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Wholesale — nondurable goods (SIC 51xx) · same major group (2-digit SIC) · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| MCKMcKESSON CORPORATION | 123.5 bn | 27.5 | — | 1.1% | +12.4% | +21% / +127% |
| CORCencora, Inc. | 67.6 bn | 26.3 | 104.3% | 0.8% | +9.3% | −4% / +74% |
| CAHCardinal Health, Inc. | 60.9 bn | 36.2 | — | 0.7% | +14.2% | +23% / +145% |
| SYYSysco Corporation | 37.9 bn | 20.5 | 59.1% | 2.1% | +3.9% | +1% / +7% |
| USFDUs Foods Holding Corp. | 23.8 bn | 33.8 | 16.4% | 1.8% | +4.1% | +40% / +151% |
| PFGCPerformance Food Group Company | 17.3 bn | 43.7 | 8.2% | 0.6% | +7.2% | +13% / +68% |
| DPZDomino’s Pizza, Inc. | 11.2 bn | 19.3 | — | 11.9% | +5.0% | −19% / −13% |
| CHEFChefs’ Warehouse, Inc. | 4.6 bn | 46.5 | 16.2% | 2.3% | +9.4% | +74% / +297% |
| ASHAshland Inc. | 3.5 bn | 126.3 | 2.8% | 2.8% | −13.7% | +44% / −4% |
| SEBSeaboard Corporation | 3.3 bn | 5.9 | 10.7% | 5.3% | +7.1% | −26% / −2% |
| HWKNHawkins, Inc. | 3.2 bn | 37.9 | 16.0% | 7.5% | +11.2% | +20% / +154% |
| UNFIUnited Natural Foods, Inc. | 2.9 bn | 36.0 | 5.3% | 0.3% | −2.0% | +29% / +232% |
| VSTSVestis Corp | 2.0 bn | — | -0.6% | -0.2% | −2.5% | +128% / −19% |
| WKCWorld Kinect Corporation | 1.9 bn | — | -11.5% | -0.4% | −12.5% | +64% / +81% |
| ANDEAndersons, Inc. | 1.9 bn | 9.3 | 16.1% | 1.8% | −2.2% | +7% / +11% |
| HLFHerbalife Ltd. | 1.6 bn | 9.1 | — | 3.4% | +0.9% | +20% / +19% |
| GLPGlobal Partners LP | 1.5 bn | 7.6 | — | 0.9% | +8.1% | −1% / +19% |
| CAPLCrossamerica Partners LP | 773.8 m | 16.1 | — | 1.2% | −10.6% | −1% / −15% |
| WEYSWeyco Group, Inc. | 616.9 m | 17.8 | 13.8% | 12.4% | −4.9% | +116% / +119% |
| MGPIMgp Ingredients, Inc. | 364.2 m | — | -34.5% | -51.4% | −23.8% | −25% / −80% |
| NUSNu Skin Enterprises, Inc. | 242.9 m | — | -32.5% | -15.7% | −14.3% | −50% / −71% |
| PTLEPTL Limited | 121.4 m | — | -24.8% | -1.6% | −27.0% | −30% / unavailable |
| HFFGHf Foods Group Inc. | 80.3 m | — | -15.5% | -2.8% | +2.2% | −41% / −69% |
| BANLCbl International Limited | 80.0 m | — | -14.0% | -0.6% | −9.1% | −48% / −86% |
| MMLPMartin Midstream Partners L.P. | 77.1 m | — | — | -1.4% | +1.2% | −25% / −24% |
1- and 3-year price returns: for HYFM from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Hydrofarm is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, with sales concentrated in the United States and Canada. The company is in a difficult period, marked by an outstanding term loan and ongoing talks with lenders, so the current question is whether it can stabilise its liquidity. Net sales for fiscal 2025 were $134.3 million 1, and in the second quarter of 2026 they fell to $23.2 million 3.
SWOT
Strengths
- The company holds a leading position in the CEA equipment niche in North America and has a broad base of wholesale customers 1.
- Proprietary brands, which make up most revenue, deliver better margins than distributed products 1.
- The company has consistently cut administrative costs, showing operational discipline in a shrinking market 3.
Weaknesses
- Liquidity is limited and debt falls due within a short period, creating uncertainty about the company's ability to continue as a going concern 12.
- Sales have fallen sharply in recent quarters, and net losses remain significant 3.
- Large impairments of intangible assets show that the value of earlier acquisitions has not been realised 1.
Opportunities
Risks
- Going concern uncertaintyhigh
The company has stated that there is substantial doubt about its ability to continue as a going concern, given recurring losses and debt due within the next twelve months 1.
- Missed interest payment and event of defaulthigh
Deferring an interest payment on the senior secured term loan triggered an event of default, and lenders reclassified the loan as current debt 2.
- Asset impairmentmedium
Major impairments recorded in the fourth quarter of fiscal 2025 show that asset values could be impaired again if the market does not stabilise 1.
- Pesticide and ingredient regulationmedium
Restrictions on certain ingredients used in grow media and nutrients could limit the sale of some products 1.
- Dependence on cannabis demandmedium
Delays in federal reform and cannabis-related risks could reduce demand and affect the company's reputation 1.
Investment thesis
What would need to be true (bull case)
- If oversupply in the cannabis industry eases and federal reform advances, demand for CEA equipment could recover, and better margins on proprietary brands could support results.
- Continued cuts to administrative costs and sales of non-core assets could improve the capital structure and liquidity 3.
- A leading position in North America and an extensive customer base could make the company attractive to strategic partners.
What would break the thesis
- If talks with lenders fail, the company could enter an insolvency process, and shareholders could lose their entire investment 1.
- Continued falls in sales and net losses could show that restructuring is not enough to restore profitability 3.
- If cannabis oversupply persists, demand for the company's products could stay low for a long period.
What to watch
- Outcome of lender negotiations over the term loan and any further extension of the forbearance periodAugust 2026
- Trend in net sales and adjusted gross margin after the sale of Aurora Peat ProductsQ3 2026
- Completion of the 2025 restructuring plan and realisation of cost savings2026
- Whether the company remains compliant with Nasdaq listing requirementsnext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Hydrofarm manufactures and distributes equipment and supplies for controlled environment agriculture (CEA), including LED lighting, climate control systems, grow media and nutrients 1. It serves over 1,800 wholesale customer accounts in the United States and Canada, with most orders placed through its proprietary online platform 1. The business model relies on proprietary brands, which carry higher gross margins than distributed brands 1.
Roughly three-quarters of net sales come from consumable products subject to regular replenishment, with the rest from durable products such as lighting and hydroponic equipment 1. The company operates manufacturing facilities in Eugene (Oregon) and Edmonton (Alberta), and distribution centres in California, Pennsylvania, British Columbia, Ontario and Spain 1.
In February 2026 Hydrofarm agreed with Quality Horticulture to act as exclusive Canadian distributor of its proprietary brands, as part of a strategy to focus on those brands 1. It later sold Aurora Peat Products and applied the proceeds to reduce debt 3.
Segments
Consumables
Grow media, nutrients and supplies make up most of sales and are subject to regular replenishment, which gives a more predictable revenue stream 1.
Durable products
Lighting and hydroponic equipment are sensitive to operators' investment cycles, and demand for these products has been weighed down by oversupply in recent periods 1.
Logistics services
The company is scaling its logistics business by using space in its distribution centres, which helps reduce facility costs 2.
Market context
The company estimates the global CEA industry was about $96 billion in 2024 and could grow substantially by 2034 1. However, the cannabis sector that drives much of Hydrofarm's demand has been hit by oversupply and falling wholesale prices, reducing indoor and outdoor cultivation 1.
The CEA equipment market in the United States and Canada is fragmented, and Hydrofarm regards itself as one of the leading companies there, though its trajectory depends on federal cannabis reform and a recovery in operator investment 1.
Trends
- Oversupply in the cannabis sectorheadwind
Overproduction has pushed wholesale cannabis prices down and reduced cultivation, which has directly weighed on demand for Hydrofarm's equipment 1.
- Federal cannabis reformmixed
Delays in federal reform, including rescheduling, could keep operator investment subdued, particularly in durable goods 1. Completed reform could support demand.
- Shift toward proprietary brandstailwind
Higher margins on proprietary brands and a narrower distributed range could improve profitability if volumes stabilise 23.
- Tariffs and trade policyheadwind
Tariffs on products imported from China and other countries can raise costs and cut margins, although the company has partly offset this through vendor negotiations 1.
Competitive position
The CEA equipment market is fragmented, with many specialist distributors and general retailers. Hydrofarm differentiates through its proprietary brand portfolio and its North American distribution network 1.
Competition also comes from suppliers that sell directly into retail, and from customers who manufacture competing products, which can pressure the company's margins 1.
- Specialty hydroponic retailers
Specialty stores are both sales channels for Hydrofarm and competitors through their own brands and direct sourcing.
- Suppliers selling directly to retail
Suppliers that choose to sell directly to consumers can become direct competitors of the distributor.
- Customers manufacturing competing brands
Customers that make and sell similar products are a source of competition for the company's portfolio.
- Garden centres and horticultural distributors
Garden centres and horticultural distributors are both customers and competitors in certain product categories.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report27 Oct 2026Material agreement · Termination of a material agreement · Item 3.02 · Item 3.03 · Amendments to articles or bylaws · Other events · Financial statements and exhibits
- Current report27 Oct 2026Other events · Financial statements and exhibits
- Current report09 Oct 2026Item 3.02 · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report14 Aug 2026
- Current report14 Aug 2026Results of operations · Financial statements and exhibits
- Current report06 Aug 2026Material agreement · Acquisition or disposition of assets · Regulation FD disclosure · Financial statements and exhibits
- Current report09 Jul 2026Delisting notice
- Current report26 Jun 2026Shareholder vote
- Current report22 Jun 2026Other events
- Quarterly report15 May 2026
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Hydrofarm Holdings Group, Inc. · 27 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Hydrofarm Holdings Group, Inc. · 14 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Hydrofarm Holdings Group, Inc. · 14 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.